AliveCor has announced KardiaMobile 6L, the first 6-lead personal ECG device to receive the FDA’s stamp of approval.
Essential reading: Top fitness trackers and health gadgets
Many had expected AliveCor to be squashed by the launch of the ECG enabled Apple Watch. But the California-based medical health company seems to be doing just fine. In fact immediately after the Series 4 launch, sales of its ECG monitors doubled. Probably as many people were not aware you could perform such measurements from the comfort of your home.
We reported late last year that AliveCor is working on a more accurate device. Unlike its earlier product range and the Series 4 Watch which have a single lead ECG, KardiaMobile 6L has a 6-lead system. In a care clinic ECG readers have 12 leads which are placed across a patient’s chest to pick up heart data. More leads mean a better view of your heart.
The FDA approved device delivers EKG leads I, II, II, aVL, aVR and aVF. All without messy gels and wires. To take a measurement rest your thumbs against the two electrodes with KardiaMobile 6L facing you. Then, touch the bottom electrode to the bare skin of your left knee or left ankle. It takes about 30 seconds to complete a reading.
The gizmo connects via Bluetooth to the accompanying smartphone app on your iPhone or Android smartphone. It can detect AFib, Bradycardia, Tachycardia and normal heart rhythm with more accuracy and detail than its competition.
AliveCor has opened pre-orders on its website, but only for the US region for now. KardiaMobile 6L costs $149 with delivery expected in 6-8 weeks. You can still purchase its more basic 1-lead monitor for $99.
Like this article? Subscribe to our monthly newsletter and never miss out!